Ranirestat + Placebo
Phase 2/3Completed 0 watching 0 views this week📈 Rising
65
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Conditions
Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Trial Timeline
Jul 1, 2009 → Feb 1, 2013
NCT ID
NCT00927914About Ranirestat + Placebo
Ranirestat + Placebo is a phase 2/3 stage product being developed by Eisai for Mild to Moderate Diabetic Sensorimotor Polyneuropathy. The current trial status is completed. This product is registered under clinical trial identifier NCT00927914. Target conditions include Mild to Moderate Diabetic Sensorimotor Polyneuropathy.
Hype Score Breakdown
Clinical
22
Activity
15
Company
10
Novelty
7
Community
8
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00927914 | Phase 2/3 | Completed |
Competing Products
20 competing products in Mild to Moderate Diabetic Sensorimotor Polyneuropathy